S100A9-induced overexpression of PD-1/PD-L1 contributes to ineffective hematopoiesis in myelodysplastic syndromes
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5551
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
S100A9-induced overexpression of PD-1/PD-L1 contributes to ineffective hematopoiesis in myelodysplastic syndromes ; day:8 ; month:2 ; year:2019 ; pages:1-13
Leukemia ; (8.2.2019), 1-13
- Creator
-
Cheng, Pinyang
Eksioglu, Erika A.
Chen, Xianghong
Kandell, Wendy
Trinh, Thu Le
Cen, Ling
Qi, Jin
Sallman, David A.
Zhang, Yu
Tu, Nhan
Adams, William A.
Zhang, Chunze
Liu, Jinhong
Cleveland, John L.
List, Alan F.
Wei, Sheng
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41375-019-0397-9
- URN
-
urn:nbn:de:101:1-2019031018071485984203
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cheng, Pinyang
- Eksioglu, Erika A.
- Chen, Xianghong
- Kandell, Wendy
- Trinh, Thu Le
- Cen, Ling
- Qi, Jin
- Sallman, David A.
- Zhang, Yu
- Tu, Nhan
- Adams, William A.
- Zhang, Chunze
- Liu, Jinhong
- Cleveland, John L.
- List, Alan F.
- Wei, Sheng
- SpringerLink (Online service)
Other Objects (12)
Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia
Myelodysplastic syndromes
Myelodysplastic syndromes
Kinetic Changes of Hematopoiesis During Aging, in Clonal Hematopoiesis of Indeterminate Potential, and in Myelodysplastic Syndromes
Feedback Signals in Myelodysplastic Syndromes: Increased Self-Renewal of the Malignant Clone Suppresses Normal Hematopoiesis
Soluble PD-L1 as a novel biomarker predicts poor outcomes and disease progression in de novo myelodysplastic syndromes
Epigenetic therapy in myelodysplastic syndromes
Myelodysplastic syndromes : with 87 tabeles
Ineffective anti PD-1 therapy after BRAF inhibitor failure in advanced melanoma
Bone marrow apoptosis in myelodysplastic syndromes
Bone marrow apoptosis in myelodysplastic syndromes
Myelodysplastic syndromes current treatment algorithm 2018
Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia
Myelodysplastic syndromes
Myelodysplastic syndromes
Kinetic Changes of Hematopoiesis During Aging, in Clonal Hematopoiesis of Indeterminate Potential, and in Myelodysplastic Syndromes
Feedback Signals in Myelodysplastic Syndromes: Increased Self-Renewal of the Malignant Clone Suppresses Normal Hematopoiesis
Soluble PD-L1 as a novel biomarker predicts poor outcomes and disease progression in de novo myelodysplastic syndromes
Epigenetic therapy in myelodysplastic syndromes
Myelodysplastic syndromes : with 87 tabeles
Ineffective anti PD-1 therapy after BRAF inhibitor failure in advanced melanoma
Bone marrow apoptosis in myelodysplastic syndromes
Bone marrow apoptosis in myelodysplastic syndromes
Myelodysplastic syndromes current treatment algorithm 2018
Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia
Myelodysplastic syndromes
Myelodysplastic syndromes
Kinetic Changes of Hematopoiesis During Aging, in Clonal Hematopoiesis of Indeterminate Potential, and in Myelodysplastic Syndromes
Feedback Signals in Myelodysplastic Syndromes: Increased Self-Renewal of the Malignant Clone Suppresses Normal Hematopoiesis
Soluble PD-L1 as a novel biomarker predicts poor outcomes and disease progression in de novo myelodysplastic syndromes
Epigenetic therapy in myelodysplastic syndromes
Myelodysplastic syndromes : with 87 tabeles
Ineffective anti PD-1 therapy after BRAF inhibitor failure in advanced melanoma
Bone marrow apoptosis in myelodysplastic syndromes
Bone marrow apoptosis in myelodysplastic syndromes